期刊文献+

性激素与心血管疾病 被引量:9

Sex hormones and cardiovascular diseases.
暂未订购
导出
摘要 性激素与心血管疾病密切相关。无论男女,雄激素均随年龄增长而下降,且与动脉粥样硬化和冠心病呈负相关。雄激素替代治疗可以改善血脂、血管内皮功能,舒张冠状动脉,缓解心绞痛症状。雌激素通过多个途径对心血管疾病产生影响,绝经后女性心血管事件的发生率迅速升高。雌、孕激素替代治疗(HRT)对心血管疾病的益处与风险存在争议,目前尚无指征采用HRT对绝经期妇女进行心血管疾病的一级或二级预防;对用于缓解更年期症状和防治绝经后骨质疏松症,则需权衡利弊,结合患者具体情况进行个体化治疗。 Sex hormones are closely linked to cardiovascular diseases. In the both genders, the level of an- drogen decreases along with advancing age, and is negatively associated with atherosclerosis (AS) and coronary heart disease. Androgen replacement therapy can improve blood lipids, vascular endothelial function, diastolic coro- nary arteries, and angina symptoms. Estrogen has a role in cardiovascular diseases via a variety of pathways, which may explain the rapid increase in cardiovascular events among postmenopansal women. There are still some de- bates over the benefits and risks of estrogen and progesterone replacement therapy (HRT) in treatment of cardio- vascular diseases. At present, there is evidence supporting the use of HRT in primary or secondary prevention of cardiovascular diseases among postmenopausal women. HRT for relief of menopausal symptoms and prevention of postmenopausal osteoporosis should be given only after the advantages and disadvantages have been weighed, and meanwhile in a personalized protocol.
作者 邓武权 陈兵
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2011年第4期266-268,共3页 Chinese Journal of Practical Internal Medicine
关键词 雄激素 雌激素 孕激素 心血管疾病 androgen estrogen progesterone cardiovascular disease
  • 相关文献

参考文献10

  • 1Khaw KT, Dowsett M, Folkerd E, et al. Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men. European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study [ J ]. Circulation ,2007,116:2694 - 2701.
  • 2Akishita M, Hashimoto M, Ohike Y, et al. Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors [ J ]. Atherosclerosis ,2010,210:232 - 236.
  • 3Webb CM, Elkington AG, Kraidly MM, et al. effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease [ J ]. Am J Cardio1,2008, 101:618 - 624.
  • 4Montalcini T, Gorgone G, Gazzaruso C, et al. Endogenous testosterone and endothelial function in postmenopausal women[ J]. Coron Artery Dis ,2007,18 :9 - 13.
  • 5Basaria S, Coviello AD, Travison TG, et al. Adverse events associ- ated with testosterone administration [J]. N Engl J Med,2010, 363 : 109 - 122.
  • 6Yeboah J, Reboussin DM, Waters D, et al. Effects of estrogen re- placement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease. [ J]. Am Heart J,2007,153: 439 - 444.
  • 7Becker A, Leber A, von Ziegler F, et al. Comparison of progression of coronary calcium in postmenopausal women on versus not on estrogen/progestin therapy[ J]. Am J Cardio1,2007 ,99 :374 - 378.
  • 8Cho L, Mukherjee D. Hormone replacement therapy and secondary cardiovascular prevention: a meta-analysis of randomized trials [ J ]. Cardiology, 2005,104 : 143 - 147.
  • 9Alexandersen P, Tanko LB, Bagger YZ, et al. The long-term impact of 2 - 3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women [J]. Climacteric, 2006,9 : 108 - 118.
  • 10Amlov J, Pencina MJ, Amin S, et al. Endogenous sex hormones and cardiovascular disease incidence in men [ J ]. Ann Intern Med,2006,145:176 - 184.

同被引文献71

引证文献9

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部